Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis

   
   

Apoptosis-modifying fusion polypeptides, and the corresponding nucleic acid molecules, are disclosed. Pharmaceutical compositions comprising these polypeptides, and the use of these polypeptides to modify apoptosis are also provided.

i polipeptidi dimodificazione di fusione e le molecole corrispondenti dell'acido nucleico, sono rilevati. Le composizioni farmaceutiche che contengono questi polipeptidi e l'uso di questi polipeptidi modificare il apoptosis inoltre sono forniti.

 
Web www.patentalert.com

< Therapeutic treatments for neuropsychiatric disorders

< Gene therapy using TGF-.beta.

> Porous particles, their aqueous dispersions, and method of preparation

> Solidifier for a liquid

~ 00112